Recent Rulings by the Court: Aqua, St. Regis Mohawk Tribe, and What Comes Next?

July 18, 2018 11:15am

Donna Meuth
Associate General Counsel, Intellectual Property
Eisai Inc. (Andover, MA)

John Thorne
Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C. (Washington, D.C.)

Chandrika Vira
Sterne, Kessler, Goldstein & Fox P.L.L.C. (Washington, D.C.)

The recent rulings by the court in the Aqua Products and St. Regis Mohawk Tribe cases left PTAB attorneys with only questions about what this means for their practice moving forward. This session will examine:  
  • After Aqua, does the burden of proof now lie with the petitioner?
  • Could future PTO rule-making changes alter the burden to show patentability of proposed substitute claims?
  • The recent PTAB ruling in Mylan Pharmaceuticals, et al. v. Allergan, Inc., and its effects going forward
  • Monitoring recent and pending federal legislation effecting the role of sovereign immunity on IP